Tom Borody CDD Building
Trust Mark

Welcome to the Centre for
Digestive Diseases


The Centre for Digestive Diseases' (CDD) mission is to provide our patients with the best possible care. We take great pride in our facilities and personnel who continuously strive to achieve excellence in every aspect of our organisation.

The Hospital houses cutting-edge technologies enabling our specialists to provide specialised treatments. For instance, CDD is one of the few institutions offering Infrared Coagulation (IRC) which promotes fast healing of haemorrhoids with relatively minimal discomfort. This and other treatments we offer allow for a more comfortable experience for our patients.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Physicians and Nurses at CDD understand the personal difficulties associated with gastrointestinal (GI) related disorders. Under the leadership of Professor Thomas Borody, efforts are channelled through the delivery of unique treatments and therapies. We endeavour to establish meaningful relationships with our patients, maintain strict standards of privacy and compassion and ensure that the efficacy of treatments is given the highest chance of success.


The Centre for Digestive Diseases (CDD), under the leadership of founder and Medical Director, Professor Thomas Borody, has distinguished itself as a unique medical institution offering novel approaches in researching, diagnosing and treating gastrointestinal (GI) conditions.

CDD offers a range of services in the day-procedure unit. Patients undergo a range of procedures in its well-equipped facilities, supported by an ISO 9002 accredited organisation consisting of 50 staff. CDD offers patients a high standard of professional care and service.

CDD also houses a Department of Research and Innovation responsible for conducting clinical trials approved by an independent Human Research Ethics Committee (HREC).

Located in Sydney Australia, CDD is internationally regarded as a unique medical institution, collaborating with pharmaceutical companies, universities and medical societies in striving to provide excellence in gastroenterology.